Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Umme Aiman Shirazi"'
Autor:
Sadia Sultan, Syed Mohammed Irfan, Mohammad Amjad Baig, Syed Mohammad Usman, Umme Aiman Shirazi
Publikováno v:
Asian Journal of Transfusion Science, Vol 11, Iss 2, Pp 151-155 (2017)
Background: Donor deferral owing to anemia is one of the major causative factors of temporary donor rejection, which is preventable and treatable. The basic knowledge about frequency, types, and severity of anemia among donors will help plan a strate
Externí odkaz:
https://doaj.org/article/ca459e52c365478da33cc501cd503f43
Autor:
Saroona Haroon, Omer Khalil Ahmed, Muhammad Irfan, Ishaq Azeem Asghar, Anoshia Afzal, Muhammad Asad Diwan, Syed J Ali, Shamail Zia, Atif Ali Hashmi, Umme Aiman Shirazi
Publikováno v:
Cureus
Introduction Metaplastic breast carcinoma (MBC) is defined as breast cancer with a heterologous non-glandular component. MBC is considered a special type of breast cancer with a prognosis that is worse than invasive ductal carcinoma (IDC) of the brea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::466286c3b39d583e23b337213ad47532
http://europepmc.org/articles/PMC8112600
http://europepmc.org/articles/PMC8112600
Autor:
Atif Ali Hashmi, Umme Aiman Shirazi, Muhammad Irfan, Syeda N Iftikhar, Omer Khalil Ahmed, Javaria Ali, Gul Nargus, Anoshia Afzal, Ishaq Azeem Asghar
Publikováno v:
Cureus
Introduction Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma. The 2016 World Health Organization (WHO) update on hematopoietic tumors suggested that all DLBCL cases should be subtyped into germinal and non-germinal center pheno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::688493acf45b92d402799ea50161fdd3
http://europepmc.org/articles/PMC7936471
http://europepmc.org/articles/PMC7936471
Autor:
Gul Nargus, Ishaq Azeem Asghar, Muhammad Irfan, Anoshia Afzal, Omer Khalil Ahmed, Javaria Ali, Atif Ali Hashmi, Umme Aiman Shirazi, Syeda N Iftikhar
Publikováno v:
Cureus
Introduction Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease, the spectrum of which is increasing with time. The 2016 World Health Organization (WHO) update on hematopoietic tumors recognized a prognostic subgroup of DLBCL called dou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad185c09041230176635d84a4a79607
http://europepmc.org/articles/PMC7937403
http://europepmc.org/articles/PMC7937403
Autor:
Umme Aiman Shirazi, Syed Mohammad Usman, Sadia Sultan, Mohammad Amjad Baig, Syed Mohammed Irfan
Publikováno v:
Asian Journal of Transfusion Science
Asian Journal of Transfusion Science, Vol 11, Iss 2, Pp 151-155 (2017)
Asian Journal of Transfusion Science, Vol 11, Iss 2, Pp 151-155 (2017)
Background: Donor deferral owing to anemia is one of the major causative factors of temporary donor rejection, which is preventable and treatable. The basic knowledge about frequency, types, and severity of anemia among donors will help plan a strate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7dd88abab49925324e748e6d85a412b
https://pubmed.ncbi.nlm.nih.gov/28970684
https://pubmed.ncbi.nlm.nih.gov/28970684